Kaival Brands receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until March 17, 2025

Kaival Brands Innovations Group, Inc.

Notification on Sept 16, 2024 of non-compliance with Nasdaq minimum bid price of $1.00 for 30 consecutive business days.
Company has 180 calendar days, until March 17, 2025, to regain compliance by closing at $1.00+ for 10 consecutive trading days.
If not cured, may qualify for an additional 180-day period by meeting other listing standards and intending a reverse stock split.
Common stock continues trading on Nasdaq Capital Market; failure to cure could result in delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.